Tirzepatide has emerged as a groundbreaking treatment for type 2 diabetes, offering promising results. However, the cost of this innovative drug and its supply have become key concerns for patients and healthcare practitioners. While tirzepatide has been cleared by regulatory agencies, its expensive nature presents a significant challenge to many.